SCHEMBL4898274

SCHEMBL4898274

CCCCCCCCCCc1ccc2c(c1)Cc1cc(CCCCCCCCCC)ccc1-2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.55
SLC6A2 P23975 3/20 0.55
SLC6A4 P31645 3/20 0.55
HTR2C P28335 2/20 0.55
DRD2 P14416 1/20 0.55
GPR3 P46089 1/20 0.51
S1PR1 P21453 1/20 0.49
ESR1 P03372 2/20 0.48
ADRA2A P08913 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
TACR2 P21452 2/20 0.48
SLC6A3 Q01959 2/20 0.48
PTGS2 P35354 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
SHBG P04278 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
HSPD1 P10809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4887234 1.00 HTR2A (0.55) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL4895814 1.00 HTR2A (0.55) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL30369240 1.00 HTR2A (0.55) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL4900272 1.00 HTR2A (0.55) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL31228811 0.98 HTR2A (0.52) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL2930325 0.98 HTR2A (0.52) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL4889569 0.92 SKP2 (0.47) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL9597806 0.92 HTR2A (0.59) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL17697931 0.92 HTR2A (0.59) HTR2ASLC6A2SLC6A4HTR2CDRD2
SCHEMBL15402535 0.91 HTR2A (0.48) HTR2ASLC6A2SLC6A4HTR2CDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084559-B2 Ethylene-vinylcyclohexane copolymers SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-27 US disclosed
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer AOC2, ACSL1, ACSL3 HTR2A 4366/4885SLC6A2 4261/4885SLC6A4 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.